VirusGEN® AAV Transfection Kits with RevIT™ AAV Enhancer
Supplier: MIRUS BIO LLC.Total Ratings: 0
Avg. Ratings: 0.0 out of 5
This novel enhancer is easily integrated into existing workflows, and it produces 2-4x higher titers across a range of serotypes, cellular growth media formulations, and transfection platforms. RevIT™ AAV Enhancer can further drive down upstream manufacturing costs by permitting the use of lower levels of plasmid DNA while maintaining high-quality titers. Continual improvements in both upstream and downstream AAV manufacturing processes will allow the next generation of gene therapies to reach a broader audience
- Designed to deliver a higher titer for any serotype, reagent, media, or cell line.
- 2-4X increase in AAV titer.
- >50% reduction in cost per dose.
- 2X doses produced per bioreactor run.
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...